(Q40661469)

English

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study

scientific article published on March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

alveolar rhabdomyosarcoma

1 reference

based on heuristic

inferred from title

Jay A Berzofsky

9

object named as

Jay A Berzofsky

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Ramzi Dagher

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Lauren M Long

2

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Elizabeth J Read

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Susan F Leitman

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Charles S Carter

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Maria Tsokos

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Theresa J Goletz

7

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Nilo Avila

8

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Lee J Helman

10

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Crystal L Mackall

11

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Pediatric Blood Cancer

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

158-164

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cytotoxic T cell response against the chimeric ETV6-AML1 protein in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Molecular confirmation of Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1002%2FMPO.1303

21 January 2018

Identifiers

10.1002/MPO.1303

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40661469&oldid=1904279034"